CompletedPhase 3

The POUR (Postoperative Urinary Retention) Study

United States171 participantsStarted 2022-04-13

Plain-language summary

The primary aim of this study will be to compare the rate of postoperative urinary retention between patients receiving Sugammadex and those receiving traditional reversal agents

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over the age of 18 * Undergoing laparoscopic inguinal hernia repair at Carolinas Medical Center by attending surgeons within the Division of Gastrointestinal and Minimally Invasive Surgery * Unilateral or bilateral inguinal hernia repair; may have concurrent umbilical hernia repair performed * Agreeable to participation in the study Exclusion Criteria: * Patients who are having concurrent ventral or flank hernias repaired at time of operation or are having an inguinal hernia repair along with another operation (e.g. laparoscopic cholecystectomy) * End-stage renal disease (Creatinine clearance less than 30) * Neuromuscular disease * Prior adverse reactions to Sugammadex * Patients who do not provide consent for the study

What they're measuring

Number of Participants With Urinary Retention

Timeframe: 6 hours postop

Trial details

NCT IDNCT05276804

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-03

Results submitted2025-05-14

View on ClinicalTrials.gov More Postoperative Urinary Retention trials